AMLX
Price
$6.41
Change
+$1.39 (+27.69%)
Updated
Jun 24, 04:59 PM (EDT)
Capitalization
447.49M
44 days until earnings call
KZIA
Price
$6.03
Change
-$0.74 (-10.93%)
Updated
Jun 24, 04:59 PM (EDT)
Capitalization
12.44M
Interact to see
Advertisement

AMLX vs KZIA

Header iconAMLX vs KZIA Comparison
Open Charts AMLX vs KZIABanner chart's image
Amylyx Pharmaceuticals
Price$6.41
Change+$1.39 (+27.69%)
Volume$119.22K
Capitalization447.49M
Kazia Therapeutics
Price$6.03
Change-$0.74 (-10.93%)
Volume$1.82K
Capitalization12.44M
AMLX vs KZIA Comparison Chart in %
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. KZIA commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a StrongBuy and KZIA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (AMLX: $5.02 vs. KZIA: $6.77)
Brand notoriety: AMLX and KZIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 81% vs. KZIA: 21%
Market capitalization -- AMLX: $447.49M vs. KZIA: $12.44M
AMLX [@Biotechnology] is valued at $447.49M. KZIA’s [@Biotechnology] market capitalization is $12.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $326.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileKZIA’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • KZIA’s FA Score: 0 green, 5 red.
According to our system of comparison, both AMLX and KZIA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 3 TA indicator(s) are bullish while KZIA’s TA Score has 5 bullish TA indicator(s).

  • AMLX’s TA Score: 3 bullish, 4 bearish.
  • KZIA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, KZIA is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Biotechnology) experienced а -7.72% price change this week, while KZIA (@Biotechnology) price change was -25.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.91%. For the same industry, the average monthly price growth was +35.46%, and the average quarterly price growth was +17.29%.

Reported Earning Dates

AMLX is expected to report earnings on Aug 07, 2025.

KZIA is expected to report earnings on Jun 10, 2025.

Industries' Descriptions

@Biotechnology (+4.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($447M) has a higher market cap than KZIA($12.4M). AMLX YTD gains are higher at: 32.804 vs. KZIA (-23.503). KZIA has higher annual earnings (EBITDA): -26.77M vs. AMLX (-206.81M). KZIA has higher revenues than AMLX: KZIA (2.31M) vs AMLX (-1.27M).
AMLXKZIAAMLX / KZIA
Capitalization447M12.4M3,605%
EBITDA-206.81M-26.77M773%
Gain YTD32.804-23.503-140%
P/E Ratio2.69N/A-
Revenue-1.27M2.31M-55%
Total Cash204MN/A-
Total Debt1.38MN/A-
FUNDAMENTALS RATINGS
KZIA: Fundamental Ratings
KZIA
OUTLOOK RATING
1..100
96
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
17

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXKZIA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 15 days ago
76%
Bullish Trend 13 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YEXT8.180.17
+2.12%
Yext
NSA32.930.52
+1.60%
National Storage Affiliates Trust
INTT6.920.03
+0.39%
inTEST Corp
ATHA0.30-0.01
-2.31%
Athira Pharma
HOOD76.35-2.19
-2.79%
Robinhood Markets

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-0.59%
XOMAO - AMLX
68%
Closely correlated
-0.21%
XOMAP - AMLX
51%
Loosely correlated
+0.23%
RGNX - AMLX
44%
Loosely correlated
-6.76%
JAZZ - AMLX
43%
Loosely correlated
-0.70%
OCUL - AMLX
43%
Loosely correlated
+2.83%
More

KZIA and

Correlation & Price change

A.I.dvisor tells us that KZIA and CLNN have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KZIA and CLNN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZIA
1D Price
Change %
KZIA100%
-26.01%
CLNN - KZIA
33%
Poorly correlated
-4.21%
RVMD - KZIA
29%
Poorly correlated
+0.96%
AVCTF - KZIA
26%
Poorly correlated
N/A
IMAB - KZIA
26%
Poorly correlated
-1.60%
AMLX - KZIA
26%
Poorly correlated
-0.59%
More